Endocrinology Thesis Topics

Ø An extensive collection of over 100,000 thesis topics is offered on the website, with approximately 10,000 topics per specialty, including a dedicated section for Endocrinology Thesis Topics.

 

Ø Numerous medical journals have been meticulously reviewed to compile a list of recent  Endocrinology Thesis Topics, ensuring resident doctors have access to the latest trends and developments within the field.

 

Ø Through personalized whatsapp guidance, support is provided to resident doctors throughout the thesis process across all broad specialties and super-specialties including assistance to choose good Endocrinology Thesis Topics.

 

Ø Thesis protocol and synopsis: assistance is given in developing a well-structured protocol and synopsis specifically tailored for Endocrinology Thesis Topics .

 

Ø Sample size determination: for studies on Endocrinology Thesis Topics  guidance is offered to determine the correct sample size using complex formulas and pilot studies, ensuring methodological precision.

 

Ø Review of literature: comprehensive support is available for conducting a thorough literature review, establishing a strong foundation for Endocrinology Thesis Topics.

 

 

Ø Statistical methods: advice is provided on selecting and applying the most appropriate statistical methods to meet the objectives of selected Endocrinology Thesis Topics.

Endocrinology Thesis Topics

Endocrinology Thesis Topics

  1. Impact of intermittent fasting on insulin sensitivity and glycemic control in patients with type 2 diabetes: A randomized controlled trial.
  2. Evaluation of bone mineral density in postmenopausal women with type 1 diabetes mellitus using dual-energy X-ray absorptiometry.
  3. Association between thyroid autoantibodies and recurrent pregnancy loss: A prospective cohort study.
  4. The role of GLP-1 receptor agonists in the management of obesity and its metabolic consequences: A systematic review and meta-analysis.
  5. Longitudinal analysis of adrenal function recovery in critically ill patients after glucocorticoid therapy.
  6. The effect of nocturnal hypoglycemia on cognitive function in children and adolescents with type 1 diabetes: A prospective observational study.
  7. Relationship between serum vitamin D levels and insulin resistance in polycystic ovary syndrome: A case-control study.
  8. The impact of subclinical hypothyroidism on cardiovascular disease risk in elderly patients: A population-based cohort study.
  9. Outcomes of patients with pheochromocytoma and paraganglioma following surgical resection: A multi-center retrospective analysis.
  10. Investigating the role of microRNA in the pathogenesis of autoimmune thyroid disease: A cross-sectional study.
  11. Comparative effectiveness of SGLT2 inhibitors and DPP-4 inhibitors on cardiovascular outcomes in type 2 diabetes patients: A nationwide cohort study.
  12. The role of metformin in modulating the gut microbiota and its impact on insulin sensitivity in obese individuals.
  13. The association between serum adiponectin levels and risk of metabolic syndrome in a large urban population: A cross-sectional study.
  14. Investigating the link between hyperthyroidism and atrial fibrillation in patients with Graves’ disease: A prospective study.
  15. The prevalence of subclinical Cushing’s syndrome in patients with incidentally discovered adrenal adenomas.
  16. Association of early-life exposure to endocrine disruptors with the development of obesity and metabolic disorders in children: A longitudinal study.
  17. The impact of bariatric surgery on hormonal changes and metabolic profile in patients with type 2 diabetes: A systematic review.
  18. The role of androgen receptor gene polymorphisms in the pathogenesis of polycystic ovary syndrome: A case-control study.
  19. Long-term outcomes and quality of life in patients with congenital adrenal hyperplasia: A nationwide registry-based study.
  20. The effect of different levothyroxine formulations on quality of life and biochemical control in patients with hypothyroidism: A randomized, double-blind crossover study.
  21. Prevalence and determinants of thyroid dysfunction in patients with chronic kidney disease: A cross-sectional study.
  22. Cross-sectional analysis of the relationship between serum leptin levels and metabolic syndrome in obese postmenopausal women.
  23. The association between serum cortisol levels and depression in patients with type 2 diabetes: A cross-sectional study.
  24. Relationship between thyroid hormone levels and lipid profile abnormalities in euthyroid individuals: A population-based cross-sectional study.
  25. Cross-sectional study on the impact of testosterone replacement therapy on bone density in men with hypogonadism.
  26. Evaluation of the prevalence of metabolic syndrome among patients with primary hyperparathyroidism: A cross-sectional study.
  27. Cross-sectional analysis of vitamin D deficiency and its association with insulin resistance in overweight and obese adults.
  28. Prevalence of adrenal insufficiency in patients with septic shock: A cross-sectional study in a tertiary care hospital.
  29. Cross-sectional study on the relationship between hypothyroidism and cognitive impairment in elderly patients.
  30. Association between insulin resistance and serum uric acid levels in patients with non-alcoholic fatty liver disease: A cross-sectional study.
  31. Prevalence of subclinical hypothyroidism among patients with metabolic syndrome: A hospital-based cross-sectional study.
  32. Cross-sectional analysis of the association between serum ghrelin levels and obesity in children and adolescents.
  33. Prevalence and risk factors of gestational diabetes mellitus in a multi-ethnic urban population: A cross-sectional study.
  34. Association between serum free testosterone levels and metabolic syndrome in women with polycystic ovary syndrome: A cross-sectional study.
  35. Cross-sectional study on the prevalence of hypopituitarism in patients with traumatic brain injury.
  36. Relationship between serum insulin-like growth factor-1 levels and metabolic syndrome in elderly individuals: A cross-sectional study.
  37. Prevalence of osteoporosis and associated risk factors in patients with type 2 diabetes: A cross-sectional study.
  38. Cross-sectional study on the prevalence of subclinical hyperthyroidism in elderly patients with atrial fibrillation.
  39. The association of thyroid function abnormalities with lipid profiles in patients with chronic liver disease: A cross-sectional study.
  40. Cross-sectional analysis of the impact of obesity on thyroid function in euthyroid women.
  41. Comparative study on the effects of continuous subcutaneous insulin infusion versus multiple daily injections on glycemic control in type 1 diabetes.
  42. Comparative study of the efficacy and safety of SGLT2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes and chronic kidney disease.
  43. Comparative analysis of bone mineral density in patients with hyperthyroidism versus hypothyroidism: A cross-sectional study.
  44. Comparative outcomes of minimally invasive versus open adrenalectomy in patients with adrenal tumors: A retrospective cohort study.
  45. Comparative effectiveness of intensive versus standard glycemic control on the progression of diabetic retinopathy in type 2 diabetes: A randomized controlled trial.
  46. Comparative study of the effects of bariatric surgery versus intensive medical therapy on cardiovascular outcomes in obese patients with type 2 diabetes.
  47. Comparative analysis of the impact of different doses of vitamin D supplementation on insulin resistance in prediabetic patients.
  48. Comparative study of the effects of low-carbohydrate versus low-fat diets on glycemic control and weight loss in type 2 diabetes: A randomized trial.
  49. Comparative effectiveness of radioiodine therapy versus antithyroid drugs in the treatment of Graves’ disease: A multicenter retrospective study.
  50. Comparative study on the effects of testosterone therapy versus placebo on metabolic syndrome components in men with late-onset hypogonadism.
  51. Comparative analysis of the prevalence and severity of diabetic neuropathy in patients with type 1 versus type 2 diabetes.
  52. Comparative study on the long-term effects of pioglitazone versus rosiglitazone on bone mineral density in postmenopausal women with type 2 diabetes.
  53. Comparative effectiveness of early versus late insulin therapy in newly diagnosed type 2 diabetes patients: A randomized controlled trial.
  54. Comparative study of the impact of different statins on glycemic control in patients with type 2 diabetes: A retrospective cohort study.
  55. Comparative analysis of the safety and efficacy of insulin degludec versus insulin glargine in elderly patients with type 2 diabetes: A randomized controlled trial.
  56. Comparative study on the effects of omega-3 fatty acid supplementation versus placebo on insulin sensitivity in overweight individuals.
  57. Comparative outcomes of patients with subclinical hypothyroidism treated with levothyroxine versus observation: A randomized controlled trial.
  58. Comparative study on the efficacy of metformin versus lifestyle modification on the progression of metabolic syndrome in obese adolescents.
  59. Comparative analysis of cardiovascular outcomes in patients with primary aldosteronism treated with surgical versus medical therapy.
  60. Comparative study of the impact of continuous glucose monitoring versus self-monitoring of blood glucose on glycemic control in type 2 diabetes.
  61. Recent advances in the development of oral GLP-1 receptor agonists for the management of type 2 diabetes.
  62. Advances in understanding the genetic basis of congenital adrenal hyperplasia: Implications for diagnosis and treatment.
  63. The role of artificial intelligence in predicting outcomes in patients with thyroid cancer: Recent advances and future directions.
  64. Recent advancements in the management of osteoporosis in patients with chronic kidney disease: A systematic review.
  65. The potential of gene therapy in the treatment of monogenic forms of diabetes: A review of recent advances.
  66. Advances in non-invasive imaging techniques for the assessment of adrenal tumors: Current perspectives and future directions.
  67. Recent developments in the pharmacological management of obesity: A focus on novel drug targets and therapies.
  68. Advances in the understanding of thyroid hormone transport and its implications for thyroid hormone replacement therapy.
  69. The role of novel biomarkers in the early diagnosis and management of diabetic nephropathy: Recent advances.
  70. Advances in the treatment of hyperparathyroidism: From conventional surgery to minimally invasive techniques.
  71. Recent advances in the management of pituitary adenomas: From surgery to targeted therapies.
  72. The role of incretin-based therapies in the prevention of cardiovascular disease in patients with type 2 diabetes: Recent advances.
  73. Advances in the understanding of the pathophysiology of insulin resistance in polycystic ovary syndrome: Implications for treatment.
  74. Recent developments in the use of continuous glucose monitoring systems in pediatric patients with type 1 diabetes.
  75. Advances in the management of hypoglycemia in patients with type 2 diabetes: From glucose tablets to glucagon analogs.
  76. The role of gut microbiota in the development of endocrine disorders: Recent advances and therapeutic implications.
  77. Recent advances in the understanding of thyroid hormone action and metabolism in critical illness.
  78. Advances in the pharmacogenomics of antidiabetic drugs: Towards personalized medicine in diabetes care.
  79. Recent developments in the use of radiofrequency ablation for the treatment of benign thyroid nodules.
  80. Advances in the use of recombinant human growth hormone in the management of growth hormone deficiency in adults.
  81. Analysis of recent studies on the role of SGLT2 inhibitors in reducing cardiovascular events in patients with type 2 diabetes.
  82. A review of recent literature on the impact of GLP-1 receptor agonists on body weight reduction and metabolic outcomes in obesity.
  83. Recent studies on the association between thyroid function and metabolic syndrome in various populations.
  84. Analysis of the latest research on the effects of vitamin D supplementation on insulin sensitivity and glucose metabolism.
  85. A review of recent advancements in the management of diabetic neuropathy with novel therapeutic agents.
  86. Recent studies on the prevalence and risk factors of gestational diabetes mellitus in different ethnic groups.
  87. Review of recent research on the efficacy of bariatric surgery in achieving remission of type 2 diabetes in obese patients.
  88. Recent studies on the impact of thyroid dysfunction on pregnancy outcomes and fetal development.
  89. Review of the latest research on the use of metformin for the treatment of polycystic ovary syndrome in adolescents.
  90. Recent studies on the association between adrenal incidentalomas and subclinical hypercortisolism: Diagnostic and therapeutic implications.
  91. Analysis of recent studies on the role of GLP-1 receptor agonists in reducing liver fat content in patients with non-alcoholic fatty liver disease.
  92. A review of recent advancements in the management of primary aldosteronism with minimally invasive surgical techniques.
  93. Recent studies on the impact of thyroid hormone replacement therapy on cardiovascular outcomes in elderly patients.
  94. Analysis of recent research on the use of testosterone therapy in men with type 2 diabetes and hypogonadism.
  95. Review of recent advancements in the management of multiple endocrine neoplasia syndromes: From genetic testing to targeted therapies.
  96. Recent studies on the impact of menopause on glucose metabolism and the risk of type 2 diabetes in women.
  97. A review of recent literature on the role of incretin-based therapies in the management of postprandial hyperglycemia in type 2 diabetes.
  98. Analysis of the latest research on the association between thyroid autoimmunity and reproductive disorders in women.
  99. Recent studies on the impact of insulin resistance on bone health in patients with type 2 diabetes: A focus on mechanisms and treatment options.
  100. Review of recent advancements in the management of hypoparathyroidism: From calcium supplementation to recombinant PTH therapy.
Don`t copy text!
×